Chapman University

Chapman University Digital Commons
Physical Therapy Faculty Articles and Research

Physical Therapy

10-21-2020

Gains Across WHO Dimensions of Function After Robot-Based
Therapy in Stroke Subjects
Jennifer Wu
Lucy Dodakian
Jill See
Erin Burke Quinlan
Lisa Meng

See next page for additional authors

Follow this and additional works at: https://digitalcommons.chapman.edu/pt_articles
Part of the Nervous System Diseases Commons, and the Other Rehabilitation and Therapy Commons

Gains Across WHO Dimensions of Function After Robot-Based Therapy in Stroke
Subjects
Comments
This is a pre-copy-editing, author-produced PDF of an article accepted for publication in
Neurorehabilitation and Neural Repair, volume 34, issue 12, in 2020 following peer review. This article may
not exactly replicate the final published version. The definitive publisher-authenticated version is available
online at https://doi.org/10.1177/1545968320956648.
The Creative Commons license below applies only to this version of the article.

Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0
License.

Copyright
The authors

Authors
Jennifer Wu, Lucy Dodakian, Jill See, Erin Burke Quinlan, Lisa Meng, Jeby Abraham, Ellen C. Wong, Vu Le,
Alison McKenzie, and Steven C. Cramer

HHS Public Access
Author manuscript
Author Manuscript

Neurorehabil Neural Repair. Author manuscript; available in PMC 2020 December 01.
Published in final edited form as:
Neurorehabil Neural Repair. 2020 December ; 34(12): 1150–1158. doi:10.1177/1545968320956648.

Gains across WHO dimensions of function after robot-based
therapy in stroke subjects
Jennifer Wu, MD, PhD1, Lucy Dodakian, MA, OTR/L1, Jill See, PT, MPT1, Erin Burke
Quinlan, PhD1,2, Lisa Meng, MS1, Jeby Abraham, DO1,4, Ellen C. Wong, MD5, Vu Le, MS1,
Alison McKenzie, PT, DPT, PhD3, Steven C. Cramer, MD1,5
1University

of California, Irvine; Orange, CA, USA

Author Manuscript

2SGDP

Centre, Institute of Psychiatry, Psychology, & Neuroscience and King’s College London;
London, England, UK
3Chapman

4Tripler

University; Irvine, CA, USA

Army Medical Center, Honolulu, HI, USA

5University

of California, Los Angeles and California Rehabilitation Institute; Los Angeles, CA,

USA

Abstract
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Background: Studies examining the effects of therapeutic interventions after stroke often focus
on changes in loss of body function/structure (impairment). However, improvements in activities
limitations and participation restriction are often higher patient priorities, and the relationship that
these measures have with loss of body function/structure is unclear.
Objective: This study measured gains across WHO International Classification of Function (ICF)
dimensions and examined their interrelationships.
Methods: Subjects were recruited 11–26 weeks after hemiparetic stroke. Over a 3-week period,
subjects received 12 sessions of intensive robot-based therapy targeting the distal arm. Each
subject was assessed at baseline and 1-month after end of therapy.

Author Manuscript

Results: At baseline, subjects (n=40) were 134.7±32.4 (mean±SD) days post-stroke and had
moderate-severe arm motor deficits (arm motor Fugl-Meyer score of 35.6±14.4) that were stable.
Subjects averaged 2,579 thumb movements and 1,298 wrist movements per treatment session.
After robot therapy, there was significant improvement in measures of body function/structure
(Fugl-Meyer score) and activity limitations (Action Research Arm Test, Barthel Index, and Stroke
Impact Scale-hand), but not participation restriction (Stroke Specific Quality of Life Scale).
Furthermore, while the degree of improvement in loss of body function/structure was correlated
with improvement in activity limitations, neither improvement in loss of body function/structure
nor in activity limitations was correlated with change in participation restriction.
CORRESPONDING AUTHOR: Steven C. Cramer, MD, University of California, Los Angeles, 710 Westwood Plaza, Reed C239, Los
Angeles, CA 90095-1769, Phone: (424) 522-7273, sccramer@mednet.ucla.edu.
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Conclusions: After a three-week course of robotic therapy, there was improvement in body
function/structure and activity limitations but no reduction in participation restriction.
Keywords
stroke; rehabilitation; outcomes research; recovery; clinical trials

INTRODUCTION

Author Manuscript

Stroke remains a leading cause of long-term disability worldwide1. Deficits in function of
the upper extremity represent a significant contributor to decreased function and quality of
life post-stroke2. Interventions such as constraint-induced movement therapy3 and robotassisted therapy4,5 have emerged as promising approaches to promote return of function
beyond that which is regained during spontaneous recovery and from conventional
rehabilitation. However, the degree to which specific interventions affect disability and
improve function after stroke is still poorly understood6,7.

Author Manuscript

Numerous outcome measures are available that assess the effect of stroke across all
dimensions of the World Health Organization (WHO) International Classification of
Function, Disability, and Health (ICF)8,9, complicating selection of appropriate
measurement tools when assessing novel rehabilitation-related interventions10,11.
Assessments of stroke-related loss of body function/structure (function/structure, previously
referred to as impairment) are often preferred given that these measurements are more
objective and easier to define1,12. In contrast, measures of activity limitations (activity) and
participation restriction (participation), while often higher patient priorities13,14, are
frequently qualitative and rely on patient self-reporting, and are therefore less commonly
used when assessing novel interventions.

Author Manuscript

In general, a limited relationship has been found across WHO ICF dimensions such as loss
of function/structure and activity12,15,16, and data are conflicting regarding the degree of
correlation that exists. For example, a meta-analysis of electromechanical and robot-assisted
arm training described high quality evidence that such interventions improve outcomes in
both function/structure and activity, but there was limited evaluation of effects on
participation17. The Fugl-Meyer (FM) motor scale18,19, a commonly employed measure of
function/structure, was shown to demonstrate robust correlation with the Action Research
Arm Test (ARAT), a measure of activity, when performed by expert raters19. On the other
hand, studies of constraint-induced movement therapy report discrepancies between
treatment-related changes in function/structure when compared to activity20. Another report
found that a majority of patients demonstrating no measurable upper extremity motor
impairment in an assessment of function/structure continued to report deficits as measured
by assessments of activity and participation21. This inconsistent relationship may be due to
numerous factors having greater influence on outcome as one moves from measurements of
function/structure to activity or participation16. For example, multiple studies have shown
improvements in patients’ functional independence measure scores (FIM, a measure of
activity) over the course of inpatient rehabilitation despite minimal change in FM total
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score22 or NIHSS23 (both assessments of function/structure), potentially related to use of
assistive devices or learning compensatory skills.
In the setting of a clinical trial on intensive robot-assisted therapy, the current study had two
primary aims. First, the study aimed to provide a detailed assessment of the effect of robotassisted therapy across all ICF dimensions. Second, the study also aimed to assess the degree
to which therapy-related improvements in function/structure were related to improvements
in activity and participation. We hypothesized that robot-assisted therapy would result in
clinically and statistically significant gains in function/structure with smaller gains in
activity and participation.

METHODS
Subject enrollment

Author Manuscript

Forty-one individuals 11–26 weeks after stroke onset gave informed consent to participate in
a longitudinal study of standardized intensive robot-assisted therapy targeting the distal arm
(clinicaltrials.gov, ID# NCT01244243). In one individual, baseline imaging revealed an
incidental finding that met exclusion criteria. Therefore, results represent the remaining 40
eligible subjects. Neuroimaging data from a subset of these subjects have previously been
reported24. Study procedures were approved by the University of California, Irvine
Institutional Review Board.

Author Manuscript

Inclusion and exclusion criteria were designed to select for individuals with a wide range of
motor deficits in whom spontaneous arm motor recovery had reached a plateau. All subjects
met the following inclusion criteria: (1) age ≥18 years; (2) hemorrhagic or ischemic stroke
with onset 11–26 weeks prior to enrollment; (3) residual arm motor deficits, defined as
ARAT score <52 or 9-hole peg test score >25% longer in the affected compared to
unaffected hand; and (4) preservation of voluntary movement in the distal upper extremity,
as demonstrated by ≥5 degrees of active range of motion in the wrist or index finger
metacarpophalangeal joint of the affected side. Individuals were excluded from the study if
they had a contraindication to MRI, severe cognitive impairment (Mini Mental Status
Examination, MMSE, score < 27), a comorbid diagnosis impacting the function of the
affected upper extremity, or unstable arm motor status. Stable arm motor status was defined
as change in FM score ≤2 points across two successive baseline assessments that spanned ≥1
week prior to initiation of robot therapy. This was a single treatment-arm study, with no
comparison or placebo group.
Robot therapy

Author Manuscript

Robot-assisted therapy consisted of 12 treatment sessions across 3 weeks. Sessions occurred
4 days/week for 2 hours/day, totaling 24 total hours of delivered therapy. All subjects
completed at least 11 of 12 prescribed robot therapy sessions. This robot has been previously
described5 (Figure 1). In brief, the robotic device has 3 degrees-of-freedom, is
pneumatically-actuated, and is back-driveable. The 3 degrees are rotational movement of the
wrist, thumb, and fingers in the plane of gravity, with the fingers moving as a single unit
about the metacarpophalangeal joint. Specifically, the device assists in power grip and
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release movements in a pattern that combines wrist extension with hand grasp, then wrist
flexion with hand release. Robot-assisted joint movement is achieved by a lever design, in
which a pneumatic cylinder is mounted at the opposite end of a lever from the limb
interface, with a revolute joint in between. Back-driveability of the robot permits the subject
to freely drive movements when active assistance is not engaged.

Author Manuscript

At the start of each session, a trained therapist (licensed occupational therapist or physical
therapist) assisted in robot adjustments to accommodate differences in hand sizes across
subjects and to ensure maximal biomechanical advantages in robot-assisted movements. The
therapist also determined the comfortable passive and active range of motion at each of the
three degrees, for each subject, and adjusted the robot’s hard stops accordingly. Movement
repetitions were calculated from each subject’s pre-treatment range of motion, such that a
movement cycle was counted when measured active movement exceeded a preset threshold
of the baseline active range of motion at a specified joint.

Author Manuscript

Each robot-assisted therapy session began with robot-assisted passive stretching, then grasprelease exercises. A wide range of real objects was placed in the hand, and the subject was
asked to describe features such as texture or temperature. Next, and occupying most of the
session were repeated grasp-release movements of the affected hand coupled to video games
(e.g., squeezed mustard onto a hot dog consumed by Homer Simpson, or hand closure in the
robot squeezed a fire extinguisher to douse a forest fire, with approval of Smokey The Bear,
Figure 1C). These games emphasized control of hand movement range, speed, and timing.
For each movement, the subject-initiated hand grasp, and if the subject did not complete the
full movement, the pneumatic cylinder was activated to assist in completing hand grasp. In
most games, movement was initiated in response to a simple computer-generated cue; in
others, movement onset time was self-initiated, in an attempt to activate supplementary
motor area25; and in others, choice of movement was guided by cues that corresponded to
regularly-changing rules displayed on the screen, in an attempt to activate dorsal premotor
cortex26. The therapist was at the patient’s side at all times to monitor and adjust robotsubject interface, clarify gameplay, and address any questions that arose. In total, the robot
recorded an average of 11,278 finger movements, 28,970 thumb movements, and 15,759
wrist movements across the 3 weeks of therapy; average movement repetitions per day were
954 for finger movements, 2,579 for thumb movements, and 1,298 for wrist movements. For
some games, hand grasp required movement of the fingers and thumb only, while other
games required movement of the wrist and thumb. As a result, the number of movement
repetitions was greatest for the thumb.
Study design

Author Manuscript

Clinical assessments were performed at three time points: (1) ≥2 weeks prior to therapy [first
baseline visit], (2) ≥1 week prior to therapy and at least 7 days after first baseline visit
[second baseline visit], and (3) 1 month following completion of therapy. Performance of
two baseline assessments prior to initiation of therapy was done in order to ensure subjects
had reached a stable plateau in motor recovery of the affected distal upper extremity.
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All clinical assessments were performed by one of two physical therapists blinded to the
subjects’ performance during therapy. The primary outcome measures were the Upper
Extremity FM Assessment18 and the ARAT27, which have good reliability, reproducibility,
and responsiveness to therapy19.

Author Manuscript

Assessments were categorized per the ICF dimensions of stroke recovery8,28 as defined by
the RehabMeasures Database at the Shirley Ryan AbilityLab (https://www.sralab.org/
rehabilitation-measures). Measures of loss of body function/structure were the FM arm
motor scale, grip strength, and pinch strength. Measures of activity limitations were ARAT,
Box and Blocks Test, Barthel Index29, and the Stroke Impact Scale30,31 hand motor domain
(SIS-hand). One measure of participation restriction was used, the Stroke Specific Quality of
Life Scale32 (SS-QOL). The FM, ARAT, and Box and Blocks Test were scored at both
baseline visits. Due to logistical issues, the SS-QOL was added after the tenth subject was
enrolled.
Statistical analysis
For FM, ARAT, and Box and Blocks assessments, evaluation of robot therapy-related
improvement was calculated with respect to the mean of the two baseline assessments. For
all other measures, therapy-related improvement was calculated with respect to scores at the
first baseline visit.

Author Manuscript

Paired testing was used to determine the statistical significance of therapy-related
improvement. Measures that were normally distributed or could be transformed to a normal
distribution were evaluated using the paired t-test, while non-normally distributed measures
were evaluated using the Wilcoxon signed-rank test. Effect size was determined using the
Cohen’s d metric for parametric measures and the Mann-Whitney U Test for nonparametric
measures. Bivariate analyses were used to determine the degree of correlation between the
changes in clinical measures using Pearson’s correlation for normally distributed measures
and Spearman’s rank correlation for non-normally distributed measures. All analyses were
two-tailed with alpha=0.05, Bonferroni corrected, and were performed using MATLAB
8.5.0 (Mathworks, Natick, MA).

RESULTS
Subject characteristics

Author Manuscript

Demographics for the 40 subjects are summarized in Table 1. Subjects were mainly righthand dominant. Across the 40 subjects, the index infarct was in the left hemisphere in 21 and
in the right hemisphere in 19. Ten individuals had more than one infarct. There was
significant variability in size and location of infarcts (33.1±50.0 cc, mean±SD). Mean time
between the two baseline assessments was 15.6±6.0 days (range 7–30 days). FM, ARAT,
and Box and Blocks Test scores did not change across the two baseline assessments
(p>0.05). Baseline scores appear in Table 2.
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Subjects demonstrated statistically significant improvement in all measures of function/
structure and activity after robot therapy, from baseline to the post-therapy assessment
(Table 2). The group did not show statistically significant change in SS-QOL, the only
measure of participation. Across all measures, the largest effect sizes were noted for
improvement in FM (d=0.57), Box and Blocks Test (d=0.48), and ARAT (d=0.46); a smaller
effect size was seen for SIS-hand (d=0.37).
Correlation across ICF dimensions

Author Manuscript

Correlations for improvements in measures both within and across ICF dimensions are
detailed in Table 3. Briefly, modest correlations were demonstrated between measures
within each ICF dimension. However, the strongest correlations were found between
measures of function/structure and activity. For example, improvements in FM were robustly
correlated with improvements in ARAT (Figure 2A, r=0.69, p<0.0001) and Box and Blocks
Test (Figure 2B, r=0.55, p=0.0002). Similarly, improvement in grip strength was correlated
with improvement in Box and Blocks Test score (r =0.52, p=0.0005). Change in SIS-hand, a
patient-reported measure of activity, did not correlate with improvements in FM or ARAT.
Changes in SS-QOL were not correlated with improvements in any measure of function/
structure or activity, including FM, ARAT, and SIS-hand.

DISCUSSION

Author Manuscript

Stroke-related deficits in upper extremity function remain a significant contributor to
disability worldwide, with persistent deficits directly linked to activity limitations,
participation restriction, poorer quality of life, and decreased subjective well-being1,21,33.
Novel interventions, including robot-assisted therapy, have been developed to reduce strokerelated disability. However, available data provide a limited understanding of the degree to
which such interventions produce changes across ICF dimensions. Furthermore, there have
been limited studies that directly examine the degree to which treatment-related gains in one
ICF dimension are associated with gains across other ICF dimensions.

Author Manuscript

The current study found that subjects who completed a course of robot-based therapy
demonstrated statistically significant improvements in stroke-related loss of body function/
structure and activity limitations, but not in participation restriction. Specifically, robotassisted therapy was associated with statistically significant gains across all measures of
function/structure and activity, including both primary endpoints: FM (a measure of
function/structure) and ARAT (a measure of activity). Estimates of the minimal clinically
important difference (MCID) for the FM and ARAT have been estimated to be 10% of the
scale maximum18,34, or 6.6 and 5.7 points respectively. Using this estimate, 17.5% of the
study patients achieved MCID on the FM, and 32.5% on the ARAT, after robot-assisted
therapy. Lo et al4 have suggested that for some subjects with chronic stroke, gains below
MCID might be clinically meaningful. SIS-hand, which is a patient-reported measure of
activity, also showed a statistically significant improvement after therapy, though effect size
was notably smaller. Improvements in measures of function/structure were robustly
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correlated with measures of activity, consistent with prior studies that found measures of
function/structure to be significantly correlated with measures of activity, including Barthel
Index, FIM, and SIS-1635,36. Together, the current results provide an in-depth examination
of the degree to which clinical improvements after robot-based therapy extend across ICF
dimensions.

Author Manuscript

Current findings are similar to previously published large-scale clinical trials in which an
experimental intervention produced significant gains in measures of function/structure and
activity, but not in measures of participation3,37,38. This difficulty to generate changes in
participation likely reflects both the multitude of factors that contribute to participation in
society and the complex interaction of such factors1. Previous studies have identified
demographic variables, socioeconomic status, injury characteristics, medical and psychiatric
comorbidities, social support, and functional status as contributors to deficits in post-stroke
participation2,39. Given that participation can be influenced by so many variables, including
those related to both the function/structure and activity dimensions40, it may be that
detection of meaningful improvements in participation requires a longer time period in order
to develop and thus an extended follow-up period, consistent with the observation from
longitudinal studies that quality of life after stroke can take months to years to manifest41. In
line with this, Wolf and colleagues found initial changes in SIS functional domains were
only followed by improvements in SIS participation domains after a period of 12–24 months
beyond when the intervention was completed42.

Author Manuscript
Author Manuscript

The high number and density of movement repetitions provided by the robot represent
several strengths of the current study. First, standardization of treatment by the robot
minimizes variability in conventional rehabilitation interventions which could confound the
relationship between improvements after robot-assisted therapy across ICF dimensions43.
Second, robot-based interventions often deliver a higher intensity of movement repetitions
compared to conventional interventions43,44. In one study, conventional therapistadministered interventions provided an average of 32 repetitions/session45, which is too few
movements to induce neural plasticity46 and an impediment to improving behavior,
particularly in higher order ICF dimensions including participation47. In contrast, patients in
the current study averaged 2,579 thumb movements and 1,298 wrist movements per
treatment session, exceeding the 600–700 repetitions per day48 in rats and the 92449
movements/day in primates considered necessary to realize functional benefits with stroke
rehabilitation. Third, each hand movement in the robot was coupled to video games. Games
promote patient involvement in health care50,51 and motivate patients to engage in enjoyable
play behavior that involves therapeutically relevant movements52,53. Use of games alters
cognitive context54 and, compared to rote movement repetition, increases activity in
cognitive networks in patients with stroke55.
After robot-assisted therapy, improvements in function/structure and activity were not
associated with improvements in participation. Recently published results from two largescale clinical trials also reported a dissociation between treatment-related motor gains and
change in measures of participation16,38. Lang and colleagues38 found that while the
majority of subjects reported overall perception of meaningful change with treatment, as a
group they did not demonstrate statistically significant improvement in measures of
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participation. A cross-sectional study31 comparing SIS with SS-QOL also reported
significant dissociation, with SIS subscores being more responsive to treatment as compared
to SS-QOL subscores. On the other hand, Roth and Lovell56 reported a correlation between
FIM scores >80 at one year post-stroke and increased community/home participation as
defined by the Frenchay Activities Index. Together, these results highlight an ongoing need
for robust, responsive, and specific measures of participation, particularly when evaluating
the effect of novel interventions for reducing stroke disability. Strikingly, in a review of the
116 instruments on www.rehabmeasures.org28 designated for stroke, only 15 instruments
were strictly participation measures. The overwhelming majority of those instruments assess
only three or four items to characterize overall quality of life, and thus provide coarse
gradation across patients. Underscoring the limited attention to participation in studies of
stroke rehabilitation therapies, a report by Salter and colleagues showed only 25% of
randomized controlled trials of stroke rehabilitation in the last four decades included an
assessment of participation57. These prior studies indicate the ongoing interest and the
paucity of knowledge regarding the translation between improvements in function/structure
and participation, changes that are more clinically meaningful to patients.

Author Manuscript
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Several limitations are associated with the current study. First, subjects were studied 11–26
weeks post-stroke. As such, it is unknown the degree to which the current findings can be
extended to patients who initiate therapy at an earlier or later time post-stroke. In addition,
while the literature reports 95% of patients with upper extremity deficits reach recovery
plateau by 11 weeks post-stroke58, the improvements demonstrated after robot-assisted
therapy (Table 2) may not be entirely attributable to the robotic intervention and instead may
be confounded by a degree of natural recovery. Any contributions of natural recovery to the
current results are likely attenuated in this study, however, as serial baseline assessments
indicated that subjects had reached stable arm motor status at the time of enrollment. The
primary endpoint of the study was at one-month post therapy, which was an additional study
limitation. It may be that any long-term changes in participation and their relationship over
time59 with structure/function and activities, were not captured as a result of this one-month
focus. Finally, reflecting the paucity of meaningful participation measures reported in the
stroke literature, the SS-QOL was the only participation measure used in the current study.
Although other measures of participation are available, the SS-QOL has been validated in
stroke patients in multiple studies60,61 and includes measures of quality of life as they relate
to upper extremity function, making it especially suited for the current study.

Author Manuscript

Though the generalizability of these results to robot-assisted therapy beyond the upper
extremity is yet unknown, studies showing correlations between function/structure of the
lower extremity62 and activity using the Barthel index35,62, SIS-1636, and FIM22,36 suggest
that further studies in other key components of movement are warranted and may show
similar relationships.
Conclusions
Novel interventions to reduce stroke disability are in development63. The current results
demonstrate robot-assisted therapy, specifically, supports improvements in stroke-related
loss of body function/structure, as well as activity limitations. The results also underscore

Neurorehabil Neural Repair. Author manuscript; available in PMC 2020 December 01.

Wu et al.

Page 9

Author Manuscript

concerns regarding the incomplete relationships between therapy-related improvement in
function/structure and activity (often the primary endpoints in clinical trials), and
improvements in participation, which are often prioritized by patients1. Ultimately, this
study highlights the need64 for further development of instruments that provide accurate,
specific, reliable, reproducible, and granulated assessments of participation restriction after
stroke.
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FIGURE 1.

(A) Diagram of subject’s posture, relationship to robot, and relationship to computer
monitor during therapy. (B) Demonstration of subject’s hand and arm interfacing with the
robot. Arrowheads denote ulnar forearm rest. White asterisks indicate soft Velcro straps
connecting the subject’s hand to the robot. (C) Example of virtual reality game, in which
hand grasp turned on fire extinguisher while grasp release turned off fire extinguisher during
Smokey the Bear game. Figure partially reprinted with permission from previously
published material5.
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FIGURE 2.

Author Manuscript

Scatterplot demonstrating the relationship between change in Upper Extremity Fugl-Meyer
Assessment score and change in (A) Action Research Arm Test (r = 0.69, p < 0.0001) and
(B) Box and Blocks Test (r = 0.55, p =0.0002). Change after robot-assisted therapy was
calculated as the absolute change in score from baseline (mean of two assessments) to 1month post-therapy assessment.
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TABLE 1:

Author Manuscript

Subject demographics
Gender

11 F / 29 M

Age, mean (SD)

58.0 (13.7) years

Time since last stroke, mean (SD)

134.7 (32.4) days

Hispanic

Ethnicity

Non-Hispanic or Latino
Asian

Race

Black or African American
White
Co-morbid medical conditions

3
37
7
5
24

Author Manuscript

Hypertension

21 N/ 19 Y

Hyperiipidemia

21 N / 19 Y

Diabetes meilitus

29 N / 11 Y

Atrial fibrillation

35 N / 5 Y

History of prior stroke

30 N/10Y
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TABLE 2:

Author Manuscript

Clinical assessments at baseline and post-treatment
Post-treatment mean (SD)

Change mean (SD)

Test statistiC† (p-value)

35.6 (14.4)

39.4 (15.0)

3.79 (3.32)

5.14 (<0.0001)

Grip strength (kg)

6 (6.5)

8.2 (8.8)

2.25 (4.54)

3.86* (<0.0001)

Pinch strength (kg)

1.9 (1.7)

2.6 (2.1)

0.64 (1.06)

3.69* (<0.0001)

ARAT

25.1 (18.7)

29.2 (19.6)

4.11 (5.86)

4.10*(<0.0001)

Box and Blocks

13.2 (15.5)

17.0 (17.8)

3.81 (5.51)

4.29* (<0.0001)

Barthel Index

88.5 (9.1)

93.3 (8.1)

4.75 (6.2)

3.89 (0.0001)

SIS-hand

2.08 (1.03)

2.6 (1.2)

0.47 (0.76)

3.28 (0.0001)

3.8 (0.57)

3.6 (0.6)

0.10 (0.50)

Baseline mean (SD)
Measures of loss of body function/struclture
Fugl-Meyer

†

Measures of activity limitations

†

Author Manuscript

†

Measures of participation restriction
SS-QOL

†

†

Student’s t-test t-Ratio is reported for normally distributed measures.

*

Wilcoxon signed-rank z-score is reported for non-normally distributed measures.
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TABLE 3:

Author Manuscript

Correlations between clinical measures
Correlation coefficient

P

Within ICF dimension correlations

Measures of loss of body function/structure (function/structure)
Fugl-Meyer

Grip strength

0.26

0.11

Fugl-Meyer

Pinch strength

0.34

0.03

Grip strength

Pinch strength

0.50

0.001*

Measures of activity limitations (activity)
ARAT

Box and Blocks

0.50

0.0009*

ARAT

SIS-hand

0.21

0.20

Box and Blocks

SIS-hand

0.41

0.008*

Author Manuscript

Across ICF dimension correlations

Author Manuscript

Function/structure

Activity

Fugl-Meyer

ARAT

0.69

< 0.0001*

Fugl-Meyer

Box and Blocks

0.55

0.0002*

Fugl-Meyer

SIS-hand

0.16

0.32

Grip strength

ARAT

0.17

0.29

Grip strength

Box and Blocks

0.52

0.0005*

Grip strength

SIS-hand

0.24

0.13

Pinch strength

ARAT

0.37

0.02

Pinch strength

Box and Blocks

0.31

0.05

Pinch strength

SIS-hand

0.35

0.03

Function/structure

Participation

Fugl-Meyer

SS-QOL

0.34

0.07

Grip strength

SS-QOL

0.11

0.56

Pinch strength

SS-QOL

0.12

0.51

Activity

Participation

ARAT

SS-QOL

0.24

0.20

Box and Blocks

SS-QOL

0.32

0.08

SIS-hand

SS-QOL

0.22

0.25

*

denotes correlations reaching statistical significance, with p<0.05, corrected for multiple comparisons
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